Bladder seen under White Light

Bladder seen under Blue Light

Confidence for Bladder Cancer Patients Making cancer visible
This video shows a bladder cancer surgery procedure (TURBT) performed with Blue Light as adjunct to White Light Cystoscopy. With courtesy of Maximillian Burger, Germany
Latest News See more news
  • 08.08.2018
    BLC with flexible scopes featured in Health News Digest

    Blue Light Cystoscopy with Cysview for surveillance cystoscopy featured in Health News Digest today:

    Blue-light Technology improves identification of Bladder Cancer. Read the story and watch the video from UT Southwestern Medical Center in Dallas, TX, U.S.A here.

  • 08.08.2018
    Results for the second quarter of 2018

    Oslo, Norway, 8 August 2018: Photocure ASA (OSE:PHO), today reported a revenue growth of 56% in local currency for the U.S. market in the second quarter of 2018, contributing to Hexvix/Cysview revenues of NOK 42.4 million (Q2 2017: NOK 37.6) and a recurring EBITDA of NOK 0.7 million (NOK -4.4 million). The company reiterates the positive outlook for the U.S. market with the reimbursement of Blue Light Cystoscopy (BLC(TM)) with Cysview, FDA approval of label expansion for Cysview and the launch of Cysview in combination with flexible cystoscopes in the surveillance of bladder cancer patients.

  • 02.08.2018
    Presentation of the second quarter and first half year 2018 results

    Photocure will present its second quarter and first half year report on Wednesday 8 August 2018 at Hotel Continental, Oslo, Norway.

Photocure, The Bladder Cancer Company, delivers transformative solutions to improve the lives of bladder cancer patients